The originality of this paper originates from our attempt to establish the predictive status of GCR, SGK1, and Bcl-2 in the BCCC cohort, which includes a multiethnic population of incident breast cancer cases with linked clinical, genetic ancestry, survival, and sociodemographic data, as well as histologic and molecular subtyping. The gene discussed is BCL2; the disease is breast carcinoma.